GL1X · GenesisL1 explorer

Ligand · N13

N13 · 2-{3-[3-(1H-benzimidazol-2-yl)-1H-indazol-6-yl]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide

N13, 2-{3-[3-(1H-benzimidazol-2-yl)-1H-indazol-6-yl]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide (C25 H18 F N7 O, 451.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…

Component
N13
Formula
C25 H18 F N7 O
Class
ligand
Structures
2
PDB entries
1

Binding sites

N13 in 2 structures; the first of them:

  • 3W18 · Structure of Aurora kinase A complexed to benzoimidazole-indazole inhibitor XIII · N13 A501 · binds LEU139, VAL147, ALA160, LYS162, GLN185, LEU194, LEU208, LEU210 and 7 more
  • 3W18 · Structure of aurora kinase a complexed to benzoimidazole-indazole inhibitor xiii · N13 A501 · binds LEU139, VAL147, ALA160, LYS162, GLN185, LEU194, LEU208, LEU210 and 7 more

Residues it binds most

LEU 4, ALA 4, GLY 4, LYS 4, GLN 4, GLU 4, PHE 2, PRO 4, TYR 4, VAL 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.